Viveve Medical (NASDAQ: VIVE)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.670 | -0.670 | 0.0000 | ||||
REV | 1.730M | 1.641M | -89.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Viveve Medical (NASDAQ: VIVE) through any online brokerage.
Other companies in Viveve Medical’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Motus GI Hldgs (NASDAQ:MOTS), NeuroOne Medical Tech (NASDAQ:NMTC), Nuwellis (NASDAQ:NUWE) and InVivo Therapeutics Hldg (NASDAQ:NVIV).
The latest price target for Viveve Medical (NASDAQ: VIVE) was reported by Ladenburg Thalmann on Tuesday, December 3, 2019. The analyst firm set a price target for 0.00 expecting VIVE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Viveve Medical (NASDAQ: VIVE) is $0.6351 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Viveve Medical.
Viveve Medical’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Viveve Medical.
Viveve Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.